The Role of Nutraceuticals in Degenerative Diseases provides a comprehensive overview of the growing role of nutraceuticals in preventing and managing degenerative disorders. As awareness increases around dietary supplements as supportive therapy, this book examines how nutraceuticals can complement conventional treatments in slowing cellular degeneration and improving quality of life. The book systematically explains the causes, mechanisms, and therapeutic approaches of major degenerative diseases, including respiratory, neurodegenerative, cardiovascular, musculoskeletal, renal, hepatic, ophthalmic, and metabolic disorders. It covers both foundational concepts of nutraceuticals and disease pathology, along with disease-specific applications supported by mechanistic insights and emerging research. Topics such as in silico identification of nutraceuticals, biomarkers, and prevention strategies are also discussed, offering a balanced view of theory and practice. Key Features Explains fundamentals, scope, and identification of nutraceuticals Describes mechanisms and progression of major degenerative diseases Examines disease-specific nutraceutical interventions across organ systems Integrates conventional therapy with dietary and preventive strategies Highlights emerging research, biomarkers, and preventive approaches.

Autoimmune Disorders and Secondary Plant Metabolites provides a crisp overview of immune system dysfunction, then examines the therapeutic potential of medicinal plants in managing major autoimmune and immune-related disorders such as Type 1 Diabetes, Multiple Sclerosis, Psoriasis, Systemic Lupus, Vitiligo, and Hashimoto's Thyroiditis. Each chapter identifies disease-specific phytochemicals, explains mechanisms of action, and highlights emerging plant-based pharmacotherapy strategies, while linking traditional pharmacology with modern molecular and diagnostic advances. Key Features - Provides disease-wise phytochemical insights. - Explains immunomodulatory mechanisms using plant bioactive compounds. - Bridges traditional and molecular pharmacology concepts. - Presents evidence through simplified tables and visuals for comparison.

Autoimmune Disorders and Secondary Plant Metabolites provides a crisp overview of immune system dysfunction, then examines the therapeutic potential of medicinal plants in managing major autoimmune and immune-related disorders such as Type 1 Diabetes, Multiple Sclerosis, Psoriasis, Systemic Lupus, Vitiligo, and Hashimoto’s Thyroiditis. Each chapter identifies disease-specific phytochemicals, explains mechanisms of action, and highlights emerging plant-based pharmacotherapy strategies, while linking traditional pharmacology with modern molecular and diagnostic advances. Key Features - Provides disease-wise phytochemical insights. - Explains immunomodulatory mechanisms using plant bioactive compounds. - Bridges traditional and molecular pharmacology concepts. - Presents evidence through simplified tables and visuals for comparison.

Neuropathy Demystified bridges medical insight with holistic wellness to support effective long-term management that empowers readers with both scientific understanding and practical guidance, providing a clear, accessible, and clinically grounded exploration of peripheral neuropathy. The book progresses from foundational concepts such as nerve anatomy, types of neuropathies, and underlying causes to detailed diagnostic pathways involving clinical evaluation, laboratory testing, and imaging. Sections also explain conventional and advanced treatment options, including medications, physiotherapy, nutrition, lifestyle modification, and innovative therapies such as regenerative and neuroprotective approaches, concluding with long-term care strategies, coping tools, preventive practices, and integrative wellness methods. Key Features Explains nerve anatomy, mechanisms, and causes of neuropathy . Clarifies diagnostic frameworks with step-by-step clinical pathways Presents pharmacological, physical, nutritional, and regenerative treatments Provides practical self-care tools and long-term management strategies Supports learning with illustrations, evidence-based insights, and wellness approaches

Brain Tumor Drug Development provides a clear, multidisciplinary update on modern therapies for glioblastoma and other aggressive brain tumors. The book focuses on improving drug precision, crossing the blood-brain barrier, identifying biomarkers, designing effective trials, and accelerating translation from research to real patient care. Key Features Discusses how to overcome the blood-brain barrier using advanced delivery methods Explains how to improve drug penetration and specificity with nano and polymer-based systems Explores new therapies through immunotherapy, gene therapy, and personalised medicine Outlines preclinical models and identifies biomarkers to support clinical success Details regulatory-aligned clinical trial strategies for faster translation

The Role of Asymmetric Synthesis in Drug Discovery presents a comprehensive overview of how enantioselective synthesis drives the development of safer, more effective therapeutics. Because the 3D arrangement of atoms profoundly affects a drug's activity, efficacy, and safety, asymmetric synthesis enables the precise production of single enantiomers-minimizing side effects and maximizing therapeutic performance. In the era of precision medicine, this selective control is indispensable for designing molecules that interact optimally with biological targets. Spanning ten chapters, the book highlights cutting-edge experimental research on the asymmetric synthesis of diverse bioactive heterocycles. Topics include foundational principles of enantioselective synthesis, chiral heterocycles, alkaloids, terpenoids, spirooxindoles, dihydropyrimidinones, piperazine derivatives, and asymmetric oxazines. Additional chapters explore chiral triazoles, benzimidazoles, and broader classes of chiral pharmaceuticals synthesized through asymmetric strategies. Together, these chapters illustrate both the scientific depth and therapeutic potential of modern asymmetric methodologies. The book serves as a forward-looking resource designed to inspire new research on chiral heterocycles and to support ongoing efforts in medicinal chemistry and drug design. Key Features: Explores core principles of enantioselective and asymmetric synthesis in drug discovery. Highlights synthetic strategies for diverse bioactive chiral heterocycles and natural products. Showcases experimental advancements in the synthesis of alkaloids, terpenoids, spirooxindoles, and more. Examines green, modern, and emerging approaches to asymmetric synthesis. Demonstrates therapeutic relevance through biological evaluations and pharmaceutical applications. Inspires future research on novel chiral scaffolds for drug development.

AI-Powered Innovations in Ophthalmic Diagnosis and Treatment is a forward-looking assessment of how artificial intelligence is redefining modern eye care. The book connects computational advancements with clinical practice, presenting a structured, multidisciplinary roadmap for integrating AI across diagnostic workflows, therapeutic decisions, patient monitoring, and future-ready developments in ophthalmology. Across seven insightful chapters, the book establishes AI-driven frameworks that enhance ophthalmic workflows through federated, reinforcement, and prompt-based learning. Subsequent chapters detail AI-enabled diagnostics for retinal, glaucoma, and ocular surface diseases, alongside governance challenges in real-world deployment. The book also explores personalized therapeutics by integrating AI with Traditional Chinese Medicine, stem cell strategies, and precision care models. It further examines next-generation technologies including LLMs, AIGC, and multi-agent systems and their transformative roles in clinical research, drug discovery, and medical education. Broader applications are highlighted through AI's connection to systemic disease surveillance and wearable healthcare. The final chapters address regulatory, ethical, and legal considerations, concluding with a visionary outlook on quantum computing and global collaboration shaping the future of ophthalmic AI. Uniting clinical evidence, computational methodologies, and patient-centred perspectives, this book provides actionable insights for implementing responsible, explainable, and scalable AI within ophthalmic practice. Key Features Introduces AI-driven frameworks enhancing diagnostic and clinical workflows in ophthalmology. Presents practical AI applications for retinal, glaucoma, and ocular surface disease detection. Explores AI-guided personalized therapeutics, including TCM integration and stem cell innovations. Examines emerging technologies such as LLMs, AIGC, and multi-agent systems in research and education. Addresses ethical, regulatory, and governance challenges in deploying medical AI. Highlights AI's role in systemic disease prediction, wearable monitoring, and next-generation healthcare models. Envisions future innovations shaped by quantum computing and global AI collaboration.

A clear and timely overview of how global climate shifts are reshaping the spread, intensity, and impact of major vector-borne diseases.The Changing Trends of Vector-Borne Diseases to Climate Change explains how rising temperatures, changing rainfall patterns, humidity levels, and global movement accelerate mosquito and tick proliferation, expand endemic zones, and increase disease severity. Focusing on dengue and Crimean-Congo Hemorrhagic Fever (CCHF), it also highlights clinical features, transmission pathways, prevention strategies, and the urgent need for surveillance and preparedness. Key Features: - Explains how climate variables drive the spread of vector-borne diseases. - Highlights major case studies, including dengue and CCHF. - Describes transmission pathways, clinical progression, and public-health risks. - Emphasizes prevention, surveillance, and global health preparedness.

Brain Tumour Drug Development provides a clear, multidisciplinary update on modern therapies for glioblastoma and other aggressive brain tumours. The book focuses on improving drug precision, crossing the blood-brain barrier, identifying biomarkers, designing effective trials, and accelerating translation from research to real patient care. Key Features Overcomes the blood-brain barrier using advanced delivery methods Improves drug penetration & specificity with nano and polymer-based systems Explores new therapies through immunotherapy, gene therapy, and personalised medicine Builds preclinical models & identifies biomarkers to support clinical success Designs regulatory-aligned clinical trial strategies for faster translation

Current and Emerging Concepts of Polycystic Ovary Syndrome – Manual from M.P. PCOS Society is a comprehensive and authoritative guide that explores the multifaceted nature of PCOS, redefining the understanding, diagnosis, and management of Polycystic Ovary Syndrome (PCOS). Drawing upon cross-disciplinary insights and multi-institutional expertise, this two-part series unravels its epidemiology, diagnostic complexities, and phenotypic diversity. It dives deep into hormonal, metabolic, genetic, and environmental dimensions to present an integrated view of the syndrome. It presents PCOS not as a single disorder, but as an evolving clinical spectrum. It serves as both a foundation for clinicians and a catalyst for future research, setting the stage for Volume II, which expands into advanced management and innovative therapeutic paradigms. Key Features Examines the global epidemiology, pathophysiology, and heterogeneity of PCOS. Clarifies diagnostic criteria and phenotypic variations through evidence-based insights. Explores hormonal, metabolic, genetic, and environmental mechanisms driving PCOS. Integrates emerging concepts from microbiome science, endocrinology, and mental health. Highlights the evolving clinical understanding shaped by interdisciplinary collaboration.